AFT Forsyth & Company Inc. lowered its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 5.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,880 shares of the company’s stock after selling 100 shares during the period. AFT Forsyth & Company Inc.’s holdings in Clorox were worth $305,000 as of its most recent filing with the SEC.
Other institutional investors have also modified their holdings of the company. Brooklyn Investment Group grew its position in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares during the last quarter. Prospera Private Wealth LLC bought a new position in shares of Clorox during the third quarter worth about $27,000. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC bought a new position in Clorox in the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial bought a new position in Clorox in the 3rd quarter valued at about $49,000. Institutional investors own 78.53% of the company’s stock.
Clorox Price Performance
Shares of NYSE CLX opened at $148.66 on Thursday. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The company has a market capitalization of $18.40 billion, a price-to-earnings ratio of 40.62, a PEG ratio of 2.52 and a beta of 0.42. The firm has a 50-day moving average of $160.30 and a two-hundred day moving average of $159.26.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 133.33%.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the stock. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson decreased their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Wells Fargo & Company increased their target price on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and increased their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, Clorox currently has a consensus rating of “Hold” and a consensus price target of $158.21.
View Our Latest Report on Clorox
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Double-Digit Gains Ahead? These 2 Cybersecurity Stocks Look Ready
- Why Are These Companies Considered Blue Chips?
- Will Falling Bond Yields Send These 2 Small Caps Soaring?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.